Market Cap 244.43M
Revenue (ttm) 0.00
Net Income (ttm) -88.85M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 932,100
Avg Vol 1,159,956
Day's Range N/A - N/A
Shares Out 87.30M
Stochastic %K 82%
Beta -0.13
Analysts Strong Sell
Price Target $19.06

Latest News on TERN

Top 3 Health Care Stocks You'll Regret Missing In Q4

Nov 19, 2024, 7:52 AM EST - 5 months ago

Top 3 Health Care Stocks You'll Regret Missing In Q4

AMRN SLN


Terns Announces Pricing of Upsized $150.15 Million Public Offering

Sep 10, 2024, 10:50 PM EDT - 8 months ago

Terns Announces Pricing of Upsized $150.15 Million Public Offering


Terns Pharmaceuticals: Weight Loss Drug TERN-601 Is Competitive

Sep 10, 2024, 10:25 AM EDT - 8 months ago

Terns Pharmaceuticals: Weight Loss Drug TERN-601 Is Competitive


Terns Announces Proposed Public Offering

Sep 9, 2024, 4:01 PM EDT - 8 months ago

Terns Announces Proposed Public Offering


Top 2 Health Care Stocks That May Collapse This Quarter

Sep 9, 2024, 9:12 AM EDT - 8 months ago

Top 2 Health Care Stocks That May Collapse This Quarter

IMVT


Terns Pharmaceuticals Announces Leadership Changes

May 8, 2024, 4:05 PM EDT - 1 year ago

Terns Pharmaceuticals Announces Leadership Changes